Reversal of the inhibitory effects of 5′Cl5′d‐(±)‐ENBA (0.1 mg/kg) on the harmaline‐induced tremor and hyperactivity by DPCPX (1 mg/kg). The number of animals: vehicle, n=10; HARM, n=10; 5′Cl‐ENBA 0.1+HARM, n=12; DPCPX 1+5′Cl‐ENBA 0.1+HARM, n=12. Statistics: ANOVA for repeated measures+LSD post hoc test. *P<.05, **P<.01, ***P<.001 vs vehicle; #
P<.05, ##
P<.01, ###
P<.001 vs HARM, ^
P=.065 vs HARM; &
P<.05, &&&
P<.001 vs 5′Cl‐ENBA 0.1+HARM. For further details, see Figures 1 and 2